G01N 2800/52
Predicting or monitoring the response to treatment
Official title: Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
G01N2800/52 (Predicting or monitoring the response to treatment) appears on 4,621 US grants and 10,945 published applications in this corpus.
Search patents in G01N- Granted patents
- 4,621
- Published applications
- 10,945
- Assignees
- 3,657
- Inventors
- 19,573
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 2 | 0 |
| 1987 | 4 | 0 |
| 1988 | 3 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 2 | 0 |
| 1992 | 4 | 0 |
| 1993 | 9 | 0 |
| 1994 | 8 | 0 |
| 1995 | 8 | 0 |
| 1996 | 8 | 0 |
| 1997 | 11 | 0 |
| 1998 | 19 | 0 |
| 1999 | 26 | 0 |
| 2000 | 30 | 0 |
| 2001 | 41 | 12 |
| 2002 | 30 | 85 |
| 2003 | 23 | 141 |
| 2004 | 29 | 116 |
| 2005 | 31 | 139 |
| 2006 | 40 | 157 |
| 2007 | 53 | 159 |
| 2008 | 50 | 162 |
| 2009 | 61 | 218 |
| 2010 | 103 | 329 |
| 2011 | 104 | 361 |
| 2012 | 112 | 410 |
| 2013 | 169 | 446 |
| 2014 | 160 | 538 |
| 2015 | 220 | 639 |
| 2016 | 238 | 757 |
| 2017 | 290 | 625 |
| 2018 | 347 | 667 |
| 2019 | 385 | 655 |
| 2020 | 353 | 682 |
| 2021 | 331 | 695 |
| 2022 | 290 | 649 |
| 2023 | 252 | 650 |
| 2024 | 279 | 667 |
| 2025 | 275 | 581 |
| 2026 | 208 | 405 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- ß-amyloid cyclic ribonucleic acid, polypeptide, and application thereof6 Oct 2026US 12,753,215 B2
- Polymeric forms of H-NOX proteins6 Oct 2026US 12,753,222 B2Omniox.Inc.
- Signature miRNA to predict neonatal opioid withdrawal syndrome (NOWS)6 Oct 2026US 12,753,442 B2The Texas A&M University Systems
- IFNβ as a pharmacodynamic marker in VSV-IFNβ-NIS oncolytic therapy6 Oct 2026US 12,754,182 B2Mayo Foundation for Medical Education and Research
- Metabolic biomarkers of inflammatory bowel disease6 Oct 2026US 12,754,192 B2Institut de Cardiologie de Montreal
- Methods of determining glucose hypometabolism-induced energy crisis and treatments thereof8 Oct 2026US 2026/0306018 A1Senovia Biosciences LLC
- Compositions, Kits, and Methods Comprising Bioidentical D BHB With Optional Vitamin B6 for Neurological Wellness, Mood Stability, and Medication Taper Support8 Oct 2026US 2026/0306430 A1Global Ketone Limited
- Composition for inducing immunotolerance8 Oct 2026US 2026/0306540 A1
- Treatment of autoimmune diseases8 Oct 2026US 2026/0308244 A1UCB Developed Brands SRL
- Detection of tumor-derived nucleic acids using red blood cells8 Oct 2026US 2026/0308689 A1
Most cited
By later US patents
- Method of implantation of a heart valve prosthesis through a tubular catheter812US 7,803,185 B22010
- Implantation system for delivery of a heart valve prosthesis464US 7,510,572 B22009
- Antibodies to human programmed death receptor PD-1454US 8,354,509 B2MSD Oss B.V. · 2013
- Macromolecular microparticles and methods of production and use294US 6,090,925 AEpic Therapeutics, Inc. · 2000
- Methods of activating a melanocortin-4 receptor pathway in obese subjects277US 8,476,227 B2Ethicon Endo-Surgery, Inc. · 2013